Remove 2003 Remove 2022 Remove Blog Remove Licensing
article thumbnail

April-July 2022 State Regulatory Developments

New Jersey Healthcare Blog

Below are the most recent health care related regulatory developments as published in the New Jersey Register in April-July 2022: April 2022. On April 4, 2022, at 54 N.J.R. On April 4, 2022, at 54 N.J.R. 290 (2022). On April 4, 2022, at 54 N.J.R. 292 (2022). On April 4, 2022, at 54 N.J.R.

article thumbnail

How the Fifty States View Electronic Data as a “Product”

Drug & Device Law

We have blogged several times about the somewhat esoteric issue of whether intangible items – chiefly computer software, website algorithms, and other electronic information – is treated as a “product” for purposes of imposing strict liability on their creators. 171, 212 (Fall 2022). 2003), review denied (Cal. Brown , 348 F.3d

article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Without an FDA license to produce another design, [defendant] was legally prohibited from distributing either [alternative design advocated by plaintiffs] at the time [plaintiff] received her vaccinations. 2003), aff’d , 810 N.Y.S.2d 3d , 2022 WL 6225596 (S.D. 2022 WL 6225661, at *5 (S.D. Wyeth Laboratories, Inc. ,

FDA 59